(Q40261563)

English

Randomized comparison of piperacillin-tazobactam plus amikacin versus cefoperazone-sulbactam plus amikacin for management of febrile neutropenia in children with lymphoma and solid tumors

scientific article published on 9 January 2013

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Randomized comparison of piperacillin-tazobactam plus amikacin versus cefoperazone-sulbactam plus amikacin for management of febrile neutropenia in children with lymphoma and solid tumors (English)

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

1 reference

based on heuristic

inferred from title

author name string

Metin Demirkaya

1

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Solmaz Celebi

2

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Betül Sevinir

3

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Mustafa Hacımustafaoglu

4

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

publication date

9 January 2013

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Pediatric Hematology and Oncology

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

30

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

141-148

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Admission clinical and laboratory factors associated with death in children with cancer during a febrile neutropenic episode

1 reference

https://api.crossref.org/works/10.3109%2F08880018.2012.756565

21 January 2018

A prospective, multicentric scoring system to predict mortality in febrile neutropenic children with cancer.

1 reference

https://api.crossref.org/works/10.3109%2F08880018.2012.756565

21 January 2018

Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the infectious diseases society of america

1 reference

https://api.crossref.org/works/10.3109%2F08880018.2012.756565

21 January 2018

A meta-analysis of antipseudomonal penicillins and cephalosporins in pediatric patients with fever and neutropenia

1 reference

https://api.crossref.org/works/10.3109%2F08880018.2012.756565

21 January 2018

Piperacillin-tazobactam and netilmicin as a safe and efficacious empirical treatment of febrile neutropenic children

1 reference

https://api.crossref.org/works/10.3109%2F08880018.2012.756565

21 January 2018

Meropenem plus amikacin versus piperacillin-tazobactam plus netilmicin as empiric therapy for high-risk febrile neutropenia in children

1 reference

https://api.crossref.org/works/10.3109%2F08880018.2012.756565

21 January 2018

Monotherapy with piperacillin/tazobactam versus cefepime as empirical therapy for febrile neutropenia in pediatric cancer patients: a randomized comparison

1 reference

https://api.crossref.org/works/10.3109%2F08880018.2012.756565

21 January 2018

Piperacillin/tazobactam versus cefozopran for the empirical treatment of pediatric cancer patients with febrile neutropenia

1 reference

https://api.crossref.org/works/10.3109%2F08880018.2012.756565

21 January 2018

Imipenem or cefoperazone-sulbactam combined with vancomycin for therapy of presumed or proven infection in neutropenic cancer patients

1 reference

https://api.crossref.org/works/10.3109%2F08880018.2012.756565

21 January 2018

Randomized comparison of sulbactam/cefoperazone with imipenem as empirical monotherapy for febrile granulocytopenic patients

1 reference

https://api.crossref.org/works/10.3109%2F08880018.2012.756565

21 January 2018

Comparison of sulbactam-cefoperazone with carbapenems as empirical monotherapy for febrile neutropenic children with lymphoma and solid tumors

1 reference

https://api.crossref.org/works/10.3109%2F08880018.2012.756565

21 January 2018

Comparison of piperacillin tazobactam and cefoperazone sulbactam monotherapy in treatment of febrile neutropenia

1 reference

https://api.crossref.org/works/10.3109%2F08880018.2012.756565

21 January 2018

Piperacillin/tazobactam versus cefepime for the empirical treatment of pediatric cancer patients with neutropenia and fever: a randomized and open-label study

1 reference

https://api.crossref.org/works/10.3109%2F08880018.2012.756565

21 January 2018

Monotherapy or aminoglycoside-containing combinations for empirical antibiotic treatment of febrile neutropenic patients: a meta-analysis

1 reference

https://api.crossref.org/works/10.3109%2F08880018.2012.756565

21 January 2018

Experience with cefepime versus meropenem as empiric monotherapy for neutropenia and fever in pediatric patients with solid tumors

1 reference

https://api.crossref.org/works/10.3109%2F08880018.2012.756565

21 January 2018

Randomized comparison of cefepime versus ceftazidime monotherapy for fever and neutropenia in children with solid tumors

1 reference

https://api.crossref.org/works/10.3109%2F08880018.2012.756565

21 January 2018

Central venous catheter use and the risk of infection in children with acute lymphoblastic leukemia: a report from the Children's Cancer Group

1 reference

https://api.crossref.org/works/10.3109%2F08880018.2012.756565

21 January 2018

The effect of right atrial catheters on infectious complications of chemotherapy in children

1 reference

https://api.crossref.org/works/10.3109%2F08880018.2012.756565

21 January 2018

Identifiers

10.3109/08880018.2012.756565

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40261563&oldid=1891230701"